ChristopherY.ThomasIVMD

Oncology • Winston Salem, NC

Genitourinary Oncology, Head & Neck Cancer, Hematologic Oncology

Associate Professor, Hematology & Oncology Urology Wake Forest Baptist Medical Center

Join to view full profile

Dr. Thomas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Thomas' full profile

Already have an account?

Office
Medical Center Blvd
Winston Salem, NC 27157
Phone+1 336-716-2255
Is this information wrong?

Education & Training

Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1978 - 1980
University of Cincinnati Medical Center/College of MedicineFellowship, Hematology and Medical Oncology, 1977 - 1978
University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 1974 - 1977
University of Kansas School of MedicineClass of 1974

Certifications & Licensure

NC State Medical License 2011 - 2025
VA State Medical License 1981 - 2018
FL State Medical License 1994 - 2002
MD State Medical License 1997 - 1999
OH State Medical License 1976 - 1976
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer Start of enrollment: 2013 Jul 08
Completed
Phase 2

Publications & Presentations

PubMed

7 citations
Phase I Study of Muscadine Grape Extract for Patients With Advanced Cancer.
Rhonda L. Bitting, Janet A. Tooze, Scott Isom, W. Jeffrey Petty, Stefan C. Grant, Rodwige J. Desnoyers, Alexandra Thomas, Christopher Y. Thomas, Angela Tatiana Alistar...> ;American Journal of Clinical Oncology. 2021 Jun 1
4 citations
Pathologic Complete Response to Neoadjuvant Nivolumab/Ipilimumab in a Patient with Metastatic Renal Cell Carcinoma.
Taylor C. Peak, Elena M Fenu, Michael B. Rothberg, Christopher Y. Thomas, Ronald L. Davis, Edward A. Levine> ;Case Reports in Urology. 2020 Nov 1
16 citations
Randomized phase II trial of cixutumumab alone or with cetuximab for refractory recurrent/metastatic head and neck squamous cell carcinoma.
Renata Ferrarotto, William N. William, Jennifer E. Tseng, Shanthi Marur, Dong M. Shin, Barbara A. Murphy, Ezra E.W. Cohen, Christopher Y. Thomas, Richard Willey, Jan C...> ;Oral Oncology. 2018 May 19
44 citations
A Phase II study of Dovitinib in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
Patrick M. Dillon, Gina R. Petroni, Bethany J. Horton, Christopher A. Moskaluk, Paula M. Fracasso, Michael G. Douvas, Nikole Varhegyi, Snjezana Zaja-Milatovic, Christo...> ;Clinical Cancer Research. 2017 Aug 1
165 citations
Adenoid cystic carcinoma: A review of recent advances, molecular targets, and clinical trials
Patrick M. Dillon, Samhita Chakraborty, Christopher A. Moskaluk, Prashant J. Joshi, Christopher Y. Thomas> ;Head & Neck. 2016 Apr 1
71 citations
Genetic markers associated with early cancer-specific mortality following prostatectomy.
Wennuan Liu, Chunmei C. Xie, Christopher Y. Thomas, Seong Tae Kim, Johan Lindberg, Lars Egevad, Zhong Wang, Zheng Zhang, Jishan Sun, Jielin Sun, Patrick P. Koty, A. Ka...> ;Cancer. 2013 Jul 1
19 citations
A theory-based decision aid for patients with cancer: results of feasibility and acceptability testing of DecisionKEYS for cancer
Patricia J. Hollen, Richard J. Gralla, Randy A. Jones, Christopher Y. Thomas, David R. Brenin, Geoffrey R. Weiss, Anneke T. Schroen, Gina R. Petroni> ;Supportive Care in Cancer. 2013 Mar 1
16 citations
p16, Cyclin D1, and HIF-1α Predict Outcomes of Patients with Oropharyngeal Squamous Cell Carcinoma Treated with Definitive Intensity-Modulated Radiation Therapy.
Asal Rahimi, David D. Wilson, Drew K. Saylor, Edward B. Stelow, Christopher Y. Thomas, James F. Reibel, David C. Shonka, Mark J. Jameson, Paul W. Read, Paul A. Levine> ;International Journal of Otolaryngology. 2012 Jul 24
31 citations
Outcomes of Patients With Head-and-Neck Cancer of Unknown Primary Origin Treated With Intensity-Modulated Radiotherapy
A. Shoushtari, Drew K. Saylor, Kara-Lynne Kerr, Ke Sheng, Christopher Y. Thomas, Mark J. Jameson, James F. Reibel, David C. Shonka, Paul W. Read, Paul A. Levine> ;International Journal of Radiation Oncology, Biology, Physics. 2011 Nov 1
68 citations
Activation of the Insulin-like Growth Factor-1 Receptor Induces Resistance to Epidermal Growth Factor Receptor Antagonism in Head and Neck Squamous Carcinoma Cells
Mark J. Jameson, Andrew D. Beckler, Linnea E. Taniguchi, Amir Allak, Lisa B. VanWagner, Nora G. Lee, William C. Thomsen, Matthew A. Hubbard, Christopher Y. Thomas> ;Molecular Cancer Therapeutics. 2011 Aug 30
33 citations
Intensity‐modulated radiotherapy outcomes for oropharyngeal squamous cell carcinoma patients stratified by p16 status
A. Shoushtari, Mathew Meeneghan, Ke Sheng, Christopher A. Moskaluk, Christopher Y. Thomas, James F. Reibel, Mark J. Jameson, Kimberly S. Keene, Paul W. Read, Paul A. L...> ;Cancer. 2010 Jun 1
19 citations
Predicting residual neck disease in patients with oropharyngeal squamous cell carcinoma treated with radiation therapy: utility of p16 status.
David C. Shonka, A. Shoushtari, Christopher Y. Thomas, Christopher A. Moskaluk, Paul W. Read, James F. Reibel, Mark J. Jameson, Paul A. Levine> ;Archives of Otolaryngology--Head & Neck Surgery. 2009 Nov 16
3 citations
Phase I study of capecitabine, carboplatin and intensity-modulated radiation therapy for head and neck cancer.
Christopher Y. Thomas, Paul W. Read, Gina R. Petroni, James F. Reibel, Paul A. Levine> ;Anticancer Research. 2009 Jul 1
7 citations
Collaboration of RON and Epidermal Growth Factor Receptor in Human Bladder Carcinogenesis
Christopher Y. Thomas, Dan Theodorescu> ;The Journal of Urology. 2006 Nov 1
5 citations
Molecular markers of prognosis and novel therapeutic strategies for urothelial cell carcinomas
Christopher Y. Thomas, Dan Theodorescu> ;World Journal of Urology. 2006 Oct 25
126 citations
Esthesioneuroblastoma: continued follow-up of a single institution's experience.
Andrew H. Loy, James F. Reibel, Paul W. Read, Christopher Y. Thomas, Steven A. Newman, John A. Jane, Paul A. Levine> ;Archives of Otolaryngology--Head & Neck Surgery. 2006 Feb 1
6 citations
THE E47 TRANSCRIPTION FACTOR BINDS TO THE ENHANCER SEQUENCES OF RECOMBINANT MURINE LEUKEMIA VIRUSES AND INFLUENCES ENHANCER FUNCTION
S C Lawrenz-Smith, Christopher Y. Thomas> ;Journal of Virology. 1995 Jul 1
8 citations
Pathogenic determinants in the U3 region of recombinant murine leukemia viruses isolated from CWD and HRS/J mice.
S C Lawrenz-Smith, A C Massey, D J Innes, Christopher Y. Thomas> ;Journal of Virology. 1994 Aug 1
10 citations
Origins of enhancer sequences of recombinant murine leukemia viruses from spontaneous B- and T-cell lymphomas of CWD mice.
A C Massey, S C Lawrenz-Smith, D J Innes, Christopher Y. Thomas> ;Journal of Virology. 1994 Jun 1
10 citations
Generation and pathogenicity of an NB-tropic SL3-3 murine leukemia virus.
Christopher Y. Thomas, J.Dean Nuckols, Cheryl F. Murphy, Don Innes> ;Virology. 1993 Apr 1
5 citations
An increase in disease latency is associated with a host-dependent selection for recombinant murine leukemia viruses with substitutions in the p15E (TM) gene.
Christopher Y. Thomas, Michael A. Coppola, J D Nuckols, S C Lawrenz-Smith, A C Massey> ;Journal of Virology. 1993 Jan 1
71 citations
Candida prosthetic arthritis: report of a case treated with fluconazole and review of the literature.
Allan R. Tunkel, Christopher Y. Thomas, Brian Wispelwey> ;The American Journal of Medicine. 1993 Jan 1
11 citations
Immunoglobulin gene rearrangement in abnormal lymph node hyperplasia.
Michael E. Williams, J. Thomas Lee, Donald J. Innes, Steven H. Swerdlow, Mark A. Lovell, Paul E. Hurtubise, Christopher Y. Thomas> ;American Journal of Clinical Pathology. 1991 Dec 1
18 citations
Origin of pathogenic determinants of recombinant murine leukemia viruses: analysis of Bxv-1-related xenotropic viruses from CWD mice.
A C Massey, Michael A. Coppola, Christopher Y. Thomas> ;Journal of Virology. 1990 Nov 1
7 citations
A host gene regulates the structure of the transmembrane envelope protein of murine leukemia viruses.
Michael A. Coppola, Christopher Y. Thomas> ;The Journal of Experimental Medicine. 1990 May 1
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

Wake Forest Baptist Health-Lexington Medical CenterLexington, North Carolina
Atrium Wake Forest BaptistWinston Salem, North Carolina